Upgrade to SI Premium - Free Trial

Editas Medicine (EDIT) PT Lowered to $15 at Stifel

May 4, 2022 3:53 PM
Stifel analyst Dae Gon Ha lowered the price target on Editas Medicine (NASDAQ: EDIT) to $15.00 (from $19.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles